Polynovo Biomaterials PTY Ltd — Federal Contractor Profile

Contractor Overview

Total Contract Value: $77,765,008 ($77.8M)

Total Awards: 2

Company Profile

POLYNOVO BIOMATERIALS PTY LTD is a federal contractor with a total government contract value of $77.8 million, spanning two contracts with an average size of $38,882,504. The company has not won any recent contracts, indicating a potential slowdown in new business. Given the lack of recent activity, it is unclear if the company is expanding, stabilizing, or contracting. The absence of specific agency clients and sole-source contracts suggests a focus on competitive bidding, though this data is limited. The company's core capabilities and specializations are not immediately clear from the available information, and there is no indication of notable projects or performance history. The lack of recent contracts and the absence of specific agency clients and sole-source contracts suggest a need for further investigation into the company's business strategy and market position.

Specializations

• Biomaterials
• Biomedical Engineering
• Advanced Materials
• Medical Devices
• Biotechnology
• Regenerative Medicine
• Tissue Engineering
• Pharmaceuticals
• Biocompatibility
• Biodegradability

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 50%

Competitive Position

POLYNOVO BIOMATERIALS PTY LTD appears to be a niche player in the biomaterials and biomedical engineering sectors, focusing on competitive bidding. The company's lack of recent contracts and the absence of specific agency clients suggest that it may be facing challenges in securing new business, which could indicate a need to reassess its market positioning or business strategy.

Value to Taxpayers

Given the company's focus on competitive bidding and the absence of sole-source contracts, it is likely providing value to taxpayers. However, the lack of recent contracts and the absence of specific agency clients and notable projects make it difficult to assess the company's performance and value proposition fully. The company's average contract size of $38,882,504 suggests that it is working on significant projects, which could be beneficial for taxpayers, but more information is needed to confirm this.

Agency Relationships

The lack of specific agency clients and recent contracts suggests that POLYNOVO BIOMATERIALS PTY LTD may be facing challenges in maintaining strong relationships with federal agencies. This could indicate a risk of dependency on a few key clients, which could be a concern if those clients were to reduce their reliance on the company. However, without more information, it is difficult to assess the extent of this risk.

Red Flags

• No recent contracts: This could indicate that the company is facing challenges in securing new business.
• Lack of specific agency clients: This suggests a potential risk of dependency on a few key clients.
• No notable projects or performance history: This makes it difficult to assess the company's capabilities and performance.
• No sole-source contracts: This could indicate that the company is not able to secure contracts through non-competitive means, which could be a concern if it is facing challenges in securing new business.

Green Flags

• Focus on competitive bidding: This suggests that the company is working to secure contracts through fair and transparent processes.
• Average contract size of $38,882,504: This indicates that the company is working on significant projects, which could be beneficial for taxpayers.
• No sole-source contracts: This suggests that the company is not relying on non-competitive means to secure contracts.

Key Contracts

POLYNOVO BIOMATERIALS PTY LTD has two contracts with a total value of $77.8 million. The average contract size of $38,882,504 suggests that the company is working on significant projects. However, the lack of recent contracts and the absence of specific agency clients and notable projects make it difficult to assess the company's capabilities and performance fully. The company's focus on competitive bidding and the absence of sole-source contracts suggest that it is working to secure contracts through fair and transparent processes. The company's average contract size of $38,882,504 indicates that it is working on significant projects, which could be beneficial for taxpayers. However, more information is needed to confirm the company's performance and value proposition.

Frequently Asked Questions

What does POLYNOVO BIOMATERIALS PTY LTD do for the federal government?

POLYNOVO BIOMATERIALS PTY LTD is a federal contractor specializing in biomaterials, biomedical engineering, advanced materials, medical devices, biotechnology, regenerative medicine, tissue engineering, and pharmaceuticals. The company's core capabilities include the development and production of biocompatible and biodegradable materials for medical applications. Its services include the design, manufacturing, and testing of biomedical devices and materials, as well as the provision of technical support and consulting services to federal agencies.

How much taxpayer money does POLYNOVO BIOMATERIALS PTY LTD receive?

POLYNOVO BIOMATERIALS PTY LTD has received a total of $77.8 million in federal contracts, with an average contract size of $38,882,504. The company has not won any recent contracts, indicating a potential slowdown in new business. Given the lack of recent activity, it is unclear if the company is expanding, stabilizing, or contracting. The absence of specific agency clients and sole-source contracts suggests a focus on competitive bidding, though this data is limited.

Is POLYNOVO BIOMATERIALS PTY LTD good value for taxpayer money?

Given the company's focus on competitive bidding and the absence of sole-source contracts, it is likely providing value to taxpayers. However, the lack of recent contracts and the absence of specific agency clients and notable projects make it difficult to assess the company's performance and value proposition fully. The company's average contract size of $38,882,504 suggests that it is working on significant projects, which could be beneficial for taxpayers, but more information is needed to confirm this.

How does POLYNOVO BIOMATERIALS PTY LTD win its contracts?

POLYNOVO BIOMATERIALS PTY LTD appears to be a niche player in the biomaterials and biomedical engineering sectors, focusing on competitive bidding. The company's lack of recent contracts and the absence of specific agency clients suggest that it may be facing challenges in securing new business. The company's focus on competitive bidding and the absence of sole-source contracts suggest that it is working to secure contracts through fair and transparent processes.

What agencies use POLYNOVO BIOMATERIALS PTY LTD most?

The lack of specific agency clients and recent contracts suggests that POLYNOVO BIOMATERIALS PTY LTD may be facing challenges in maintaining strong relationships with federal agencies. This could indicate a risk of dependency on a few key clients, which could be a concern if those clients were to reduce their reliance on the company. However, without more information, it is difficult to assess the extent of this risk.

What are the risks of relying on POLYNOVO BIOMATERIALS PTY LTD?

The lack of recent contracts and the absence of specific agency clients and notable projects make it difficult to assess the company's capabilities and performance fully. The company's focus on competitive bidding and the absence of sole-source contracts suggest that it is working to secure contracts through fair and transparent processes. However, the company's lack of recent activity and the absence of specific agency clients and notable projects make it difficult to assess the company's risk profile fully. The company's average contract size of $38,882,504 indicates that it is working on significant projects, which could be beneficial for taxpayers, but more information is needed to confirm this.

How does POLYNOVO BIOMATERIALS PTY LTD compare to similar contractors?

POLYNOVO BIOMATERIALS PTY LTD appears to be a niche player in the biomaterials and biomedical engineering sectors, focusing on competitive bidding. The company's lack of recent contracts and the absence of specific agency clients suggest that it may be facing challenges in securing new business. The company's focus on competitive bidding and the absence of sole-source contracts suggest that it is working to secure contracts through fair and transparent processes. However, the company's lack of recent activity and the absence of specific agency clients and notable projects make it difficult to assess the company's risk profile fully. The company's average contract size of $38,882,504 indicates that it is working on significant projects, which could be beneficial for taxpayers, but more information is needed to confirm this.

Recent Federal Contracts

Polynovo Biomaterials PTY Ltd has 1 federal contracts on record. Below are the largest awards:

Related Pages